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First imported case of tick-borne encephalitis in Spain – was it 
alimentary? 
 
Dear Editor,  
 
As described by Kerlik, et al, tick-borne encephalitis (TBE) is an emerging infection in 
Europe and alimentary transmission is increasingly being reported in some European 
countries [1,2]. However, this is not the case in Spain where no previous cases have been 
reported [2,3]. Herein, we describe an imported case of TBE in Spain in a boy who 
probably acquired the virus by ingestion of contaminated milky products in a trip to 
Estonia.  
 
An 18-year-old man with no previous medical history presented to the Emergency Room 
(ER) with high temperature and headache. He travelled to Hiiumaa, Estonia, where he 
had been working as a volunteer in a workcamp in a farm for three weeks, from 8th to 
29th July 2019.  During his stay in Estonia he participated in different farm activities such 
as taking care and milking sheep and goats and he consumed unpasteurized milk. He 
also reported that during the first week of his stay in the farm, three mates of the patient 
got ill, being diagnosed with TBE. The patient did not refer any tick bite and he had not 
been vaccinated against TBE before travelling.  
On 28th July, the patient presented with headache, weakness, myalgia, vomiting, walking 
imbalance and fever up to 39ºC. After 5 days, he consulted at the ER were meningeal 
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signs were detected. Blood tests showed mild elevation of acute phase reactants, 
leukocytosis with neutrophilia, lymphopenia and thrombopenia. Under the clinical 
suspicion of acute meningitis, a lumbar puncture was performed, revealing lymphocytic 
pleocytosis with hyperproteinorrachia and normal glucose concentration levels in 
cerebrospinal fluid (CSF) (see Fig. 1). Empirical treatment with beta-lactams and 
doxycycline was then started. Blood and CSF cultures resulted negative. A multiplex 
polymerase chain-reaction (PCR) on CSF sample was performed, allowing to discard 
common bacterial, viral and fungal causes of central nervous system infections. HIV 
serology and HIV viral load resulted negative. West-Nile virus RT-PCR, a flavivirus generic 
RT-PCR and Borrelia antibodies were tested in CSF and resulted negative. Serologies for 
Coxiella burnetii, Borrelia burgdorferi, Brucella spp., Rickettsia conorii, Leptospira spp. 
and Treponema pallidum were also negative.  
A commercial immunofluorescence assay (Euroimmun, Lübeck, Germany) detecting 
antibodies against West Nile, Japanese encephalitis, yellow fever and TBE viruses was 
used in CSF and serum samples. Antibodies against TBE were detected in a CSF samples 
obtained 6 days after the onset of symptoms (d.o.s) at a low titer (1:4) with no cross-
reactivity observed against the other flaviviruses tested. Subsequent serum sample 
collected eight d.o.s tested negative against IgM and IgG against dengue (ELISA, Panbio 
Diagnostics) and against West Nile (ELISA, Focus Diagnostics) and positive for IgM (titer 
1:80) and IgG (titer 1:320) against TBE, with only minimal cross reactivity observed in 
IgG against Japanese encephalitis (titer 1:20). In a convalescent sample obtained 31 
d.o.s, IgG antibodies against TBE were positive at a titer of 1:2560 (see Fig. 1). The 
detection of TBE IgM antibodies in CSF, specific TBE IgM and IgG in serum, and the 8-
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folds increase of TBE IgG antibodies in paired serum samples fulfilled the European 
Union case definition criteria for a laboratory confirmed case of TBE [4]. 
Diagnosis of TBE, probably acquired by consumption of unpasteurized milky products 
[1], was then confirmed. Brain Magnetic Resonance Imaging (MRI) did not show any 
alteration. The patient presented a very good evolution, allowing to discontinue the 
antibiotic treatment and being discharged after 7 days of admission.  
However, three weeks later the patient presented a mild non-disabling distal tremor on 
the right upper limb. A new brain MRI was unremarkable and anti-NMDAR antibodies 
resulted negative, allowing to rule out an auto-immune induced encephalitis. After three 
months, the patient was completely recovered, allowing him to return to his daily 
activities (see Fig. 1). 
 
Tick-borne encephalitis (TBE) is an infection caused by a flavivirus, usually transmitted 
by Ixodes ticks. Concerning European countries, TBE mainly affects countries in central 
and eastern Europe. Interestingly, Ixodes ricinus is widely distributed through all Europe 
including Spain and seroprevalence studies in dogs reported circulation of TBE virus in 
Spain [5]. However, no human cases of TBE in Spain have been reported in peer-review 
journals. In fact, there was no surveillance system for TBE until 2013. From then on, no 
cases in humans have been neither reported in Spain in National or International 
Surveillance Reports [3]. Besides being transmitted through tick bites, TBE can also be 
acquired after consumption of unpasteurized contaminated milky products, what has 
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been occasionally associated with TBE outbreaks, especially in some Central-Eastern 
European countries [1].  
So far, we described an imported case of TBE in Spain in an 18-year-old boy who 
travelled to Estonia, who probably acquired the virus by ingestion of contaminated dairy 
products. Being tick-borne diseases one of the major concerns in emerging infections 
disease in Europe, surveillance of such entities is crucial. Moreover, infrequent 
transmission routes, such as in our case should be considered.  
Our report highlights the importance of monitoring infections such as TBE to be aware 
of imported emerging infections such as arthropod-borne diseases, especially in non-
endemic countries. On the other hand, pre-travel consultation and vaccination when 




Figure - Chronology of symptoms and serological evolution of the case. Onset of symptoms (day 0). Timeline divided into weeks (lower 
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